Business
CardioComm Solutions Trade Mission to Japan and Korea Yields 25 Meetings with Technology Companies on Integration, Distribution and Co-Development Opportunities
Toronto, Ontario--(Newsfile Corp. - March 5, 2018) - CardioComm Solutions, Inc. (TSXV: EKG) ...
About this update from Cardiocomm Solutions, Inc.
[{"type":"text","content":"CardioComm Solutions Trade Mission to Japan and Korea Yields 25 Meetings with Technology Companies on Integration, Distribution and Co-Development OpportunitiesSoftware and Device Technologies for Remote Patient Monitoring Were Met With Great InterestToronto, Ontario--(Newsfile Corp. - March 5, 2018) - CardioComm Solutions, Inc. (TSXV: EKG) (\"CardioComm\" or the \"Company\") is pleased to announce that it held business meetings with 25 technology companies during an Ontario Trade Delegation visit to Japan and Korea from February 20 to 27. The meetings were arranged through the assistance of the Ontario Ministry of International Trade with Global Affairs Canada representatives in Japan and Korea, the Osaka Prefecture Government, Economic Affairs Government of Ontario at the Embassy of Canada to Korea, Intralink Limited and direct marketing efforts by CardioComm. The Company confirmed the likelihood of letters of intent and cooperation agreements to result over the next few months.CardioComm used this Trade Mission to: (1) meet with regional device manufacturers interested in HeartCheck™ compatibility certification; (2) pursue telemedicine partnership opportunities at a time when Japan is implementing new telemedicine initiatives; and, (3) demonstrate near-real-time remote patient monitoring using the Company's SMART Monitoring ECG reading telemedicine technology and its newest wireless consumer and hospital use ECG /arrhythmia monitoring Bluetooth connected devices. The Company provided attendees at the Japan Medical 2018 exhibition a preview of the Company's pipeline of up and coming wirelessly connected devices which includes 12 lead ECG SMART shirts, ECG sensing fitness bands, handheld devices and a 12 lead ECG chest band. These devices are already pre-qualified as HeartCheck™ compatible and have connectivity to CardioComm's GEMS™ Mobile Smartphone ECG management app and to its GEMS™ software platform which is currently utilized by hospitals across the USA and Canada.The Company also demonstrated its GEMS™ Mobile Rx app intended for use by physicians on Android and iOS based Smartphones and tablets. GEMS™ Mobile Rx enables healthcare professionals to now use ECG interrogation tools previously available only on the server based GEMS™ WIN hospital software on their own Smartphone...